Coronavirus News LATEST Updates: An expert panel of India’s central drug authority on Saturday recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar direction for the Oxford COVID-19 vaccine, reports said. Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Saturday again deliberated on the emergency use authorisation (EUA) application of the Hyderabad-based pharmaceutical firm after it submitted additional data, facts and analysis subsequent to Friday’s review meeting, a source said. The School and Mass Education department of the Odisha government on Saturday said that lectures for Class 10 and 12 will reopen from 8 January. Schools will be strictly following the COVID-19 protocol SOP. Nearly 75 health workers underwent dummy vaccination at Bhopal in Madhya Pradesh on Saturday as part of the first dry run of COVID-19 vaccine programme in the state. The mock vaccination programme was conducted at three health centres in the state capital — Gandhi Nagar community health centre (CHC), Govindpura CHC and L N Hospital. As part of the process, SMSs were sent to the health workers, in which they were asked to come to these health facilities. “After the dummy vaccination shots were given to them, these health workers were asked to wait for 30 minutes at the centres so that they are kept under observation, like in the actual vaccination plan,” PTI quoted an official as saying. Four people who recently returned to Gujarat from the United Kingdom (UK) have tested positive for the new strain of coronavirus, a top state health department official said on Saturday. Results of the 15 samples that had tested positive for coronavirus on arrival in Ahmedabad from the UK are currently pending with the National Institute of Virology (NIV) in Pune. “All the passengers who had reached Ahmedabad from the UK were screened, and the samples of those who had tested positive for coronavirus were sent to the NIV. We have received intimation that the UK strain of coronavirus has been detected in four such cases,” Principal Secretary (Health), Jayanti Ravi told reporters. Union aviation minister Hardeep Singh Puri said on Saturday that flights from India to UK will resume from 6 January, while services from that country to India will resume from 8 January onwards. “Resumption of flights between India & UK: India to UK from 6 Jan 2021. UK to India from 8 Jan 2021. 30 flights will operate every week. 15 each by Indian & UK carriers,” Puri said on Twitter. “This schedule is valid till 23 Jan 2021. Further frequency will be determined after review,” he added. Earlier, Puri had announced on Friday that only 30 flights per week will operate between India and the UK when services resume from 8 January and that this arrangement will continue till 23 January. The government will give priority to 1 crore healthcare workers and 2 crore frontline workers when India begins the rollout of the COVID-19 vaccine. Each passenger arriving from the UK would have to bring his or her COVID-19 negative report from a test done 72 hours prior to the journey, the health ministry said. While reviewing preparations for the exercise, the health minister also appealed to everyone to not believe in rumours and emphasised that the COVID-19 vaccine was safe. The total confirmed coronavirus cases in India have risen to 1,03,05,788 on Saturday after 19,079 fresh infections were registered in a day, said the Union health ministry. With the death of 224 more COVID-19 patients in the past 24 hours, the toll due to the novel coronavirus in India reached 1,49,218, the Union health ministry said on Saturday. The COVID-19 dry run is being conducted in 116 districts across 259 sites. Some 96,000 vaccinators have been trained for this, the health ministry had said. An expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended grant of permission for restricted emergency use of Oxford COVID-19 vaccine Covishield in India, subject to certain regulatory provisions, official sources said. As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated. The SEC, which earlier had sought additional safety, immunogenicity and efficacy data from SII and Bharat Biotech, deliberated on their applications seeking emergency use authorisation (EUA) for their shots on Wednesday, and met again on Friday to review the matter. While granting emergency use approval for the Oxford COVID-19 vaccine, the panel imposed certain regulatory provisions, including that the shot is indicated for active immunisation in individuals of 18 years or more to prevent the disease and that it should be administered intramuscularly in two doses at an interval of 4 to 6 weeks. Further, the SII should submit safety, efficacy and immunogenicity data from the ongoing clinical trials in the country and across the globe for review at the earliest. Also, the Pune-based firm should submit the safety data including the data on adverse event following immunisation (AEFI) and adverse event of special interest (AESI) with due analysis every 15 days for the first two months and monthly thereafter till the completion of the ongoing clinical trial in the country. The Pune-based Serum Institute of India (SII), the world’s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield. While considering Bharat Biotech’s application, the SEC noted that the ongoing clinical trial is a large one with 25,800 subjects of which 22,000 have been enrolled, including subjects with comorbid conditions, which has demonstrated safety till date but efficacy is yet to be demonstrated. “After detailed deliberation, the committee recommended that the firm should try to expedite the recruitment and may perform interim efficacy analysis for further consideration of restricted emergency use approval,” an official source said. Pfizer’s application was not deliberated, sources said. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Wednesday had approved the COVID-19 vaccine developed by scientists at Oxford University and produced by AstraZeneca for human use. “In terms of safety, Covishield was well tolerated with respect to solicited adverse events. Majority of solicited reactions were mild in severity and resolved without any sequelae. Therefore, Covishield is safe and can be used effectively for prevention of COVID-19 in the targeted population. Thus, the benefit to risk ratio strongly supports the widespread use of Covishield,” the EUA application signed by Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs at Serum Institute of India (SII), had stated. SII had applied to the Drugs Controller General of India (DCGI) for EUA for Oxford COVID-19 vaccine on 6 December, while the Hyderabad-based Bharat Biotech had sought the nod for its indigenously developed Covaxin on 7 December. Pfizer had applied for regulatory approval for its vaccine on 4 December.
Coronavirus News Updates: COVID-19 expert panel recommends emergency use authorisation for Bharat Biotech's COVAXIN
Coronavirus News LIVE Updates: Covaxin has been indigenously developed by Bharat Biotech in collaboration with the ICMR
)
Rajasthan imposes night curfew in 13 districts
The Rajasthan government on Saturday imposed night curfew from 8 pm to 6 am in 13 districts in the state. Curfew has been imposed within the urban limits of district headquarter towns in 13 districts – Kota, Jaipur, Jodhpur, Bikaner, Udaipur, Ajmer, Alwar, Bhilwara, Nagore, Pali, Tonk, Sikar and Ganganagar, reports said.
Vaccination dry run conducted “smoothly” in Sikkim
The Sikkim government on Saturday conducted a dry run for COVID-19 vaccination at an urban PHC in Gangtok, a senior health official was quoted by PTI as saying. The dry run was conducted smoothly and strengths and disadvantages were known, State Immunisation Officer Dr P Denzongpa said.
“We are fully prepared to conduct the actual COVID-19 vaccination. We have strengthened our cold storage units. All district hospitals and even PHCs already have the necessary infrastructure in place because of other routine vaccination drives held earlier across the state,” Denzongpa told PTI.
The list of first beneficiaries of the COVID-19 vaccine has been prepared, she said.
Bharat Biotech vaccine candidate approved ’especially in context of virus mutation’
The Subject Expert Commitee of the Central Drugs Standard Control Organisation (CDSCO) granted the permission for the emergency use of COVAXIN, emphasising on the “context of infection by mutant virus strains”, PTI reported.
The SEC’s recommendations will now be considered by the Drugs Controller General of India (DCGI), who will grant the final approval, News18 reported.
SEC recommends permission to Ahmedabad-based lab to conduct phase 3 trials
After detailed deliberations, the SEC has also recommended for grant of permission to Cadila Healthcare Ltd in Ahmedabad for conduct of phase-3 clinical trial protocol for its vaccine candidate.
CDSCO panel recommends granting approval for Bharat Biotech’s Covaxin
An expert panel of India’s central drug authority on Saturday recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar direction for the Oxford COVID-19 vaccine, reports said.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Saturday again deliberated on the emergency use authorisation (EUA) application of the Hyderabad-based pharmaceutical firm after it submitted additional data, facts and analysis subsequent to Friday’s review meeting, a source said.
37 UK returnees test positive for COVID-19 in Kerala
Thirty-seven people who returned from the UK to Kerala recently have tested positive for COVID-19, while the state recorded 5,328 new cases and 4,985 recoveries on Saturday, Health Minister KK Shailaja said. While the virus caseload has gone up to 7,71,251, as many as 7,02,576 people have recovered.
At least 2,40,490 people are under observation in various districts, including 11,811 in hospitals. The minister also said the dry run for the COVID-19 vaccine was successfully held and asserted the state was fully prepared to receive and administer the vaccine.
COVID-19 vaccines don’t belong to any political party, says Omar Abdullah
COVID-19 vaccines do not belong to any political party, but humanity, National Conference leader Omar Abdullah said on Saturday, hours after Samajwadi Party chief Akhilesh Yadav termed coronavirus vaccines to be rolled out in the country as “vaccine of the BJP". Taking to Twitter, the former Jammu and Kashmir chief minister said, “I don’t know about anyone else but when my turn comes I’ll happily roll up my sleeve & get a COVID vaccine.”
The more people get vaccinated, the better it will be for the country and the economy, the NC vice president said. “No vaccine belongs to any political party, they belong to humanity & the sooner we get vulnerable people vaccinated the better,” he tweeted.
3,218 new COVID-19 cases in Maharashtra, 51 deaths
Maharashtra’s COVID-19 tally on Saturday rose to 19,38,854 as the state recorded 3,218 new cases of infection, a health department official said. With 51 fatalities being reported during the day, the toll reached 49,631.
A total of 2,110 patients were discharged after treatment, taking the tally of recovered persons to 18,34,935. With this, there are 53,137 active coronavirus patients in the state now.
Mumbai city reported 593 new cases during the day, which pushed its case count to 2,94,660, while its toll rose to 11,132 with seven patients dying.
One primary contact of UK returnee tests positive for new virus strain in Karnataka
One primary contact of a UK returnee was among 10 people who tested positive for the new strain of coronavirus and all of them are undergoing treatment, Karnataka Health Minister K Sudhakar said on Saturday.
“Ten people have so far been confirmed with the new variant of coronavirus infection… nine of them are returnees from the UK., while one is a contact, the mother of one them. All of them are undergoing treatment and are without any serious health condition. They will recover soon,” he said.
Odisha govt to begin lectures for Class 10, 12 from 8 Jan
The School and Mass Education department of the Odisha government on Saturday said that lectures for Class 10 and 12 will reopen from 8 January. Schools will be strictly following the COVID-19 protocol SOP.
ICMR says India ‘successfully’ cultured new viral strain
The Indian Council of Medical Research (ICMR) on Saturday issued a statement that India has “successfully cultured” the new COVID-19 strain that has been detected in the UK.
Japanese governors demand state of emergency
The Japanese capital, Tokyo, and three nearby prefectures have asked the national government to declare a state of emergency to curtail the surging spread of the coronavirus pandemic.
In the name of valuing life, we made this plea together, said Tokyo Gov. Yuriko Koike after meeting for three hours on Saturday with the minister in charge of coronavirus measures, along with the governors of Saitama, Chiba and Kanagawa.
Japan has seen a recent rise in reported cases of COVID-19, especially in urban areas. Tokyo saw a daily record of 1,337 cases on New Year’s Eve.
Worries are growing about hosting the Olympics, set for July, with 11,000 Olympic athletes set to enter Japan, as well as tens of thousands of officials and media.
AstraZeneca plans 2m doses a week of vaccine for UK, say reports
Amidst growing pressure over sufficient supplies of COVID-19 vaccines in the UK, pharmaceutical companies have hit back at government claims that access to enough jabs was a “limiting factor”, insisting there was no issue at their end.
While AstraZeneca says it expects 2 million doses of the Oxford University vaccine to be ready each week in just over a fortnight, Pfizer BioNTech said the number of doses it has now sent to the UK is “in the millions”.
COVID-19 vaccine dry run carried out on 75 health workers in Bhopal
Nearly 75 health workers underwent dummy vaccination at Bhopal in Madhya Pradesh on Saturday as part of the first dry run of COVID-19 vaccine programme in the state. The mock vaccination programme was conducted at three health centres in the state capital — Gandhi Nagar community health centre (CHC), Govindpura CHC and L N Hospital.
As part of the process, SMSs were sent to the health workers, in which they were asked to come to these health facilities. “After the dummy vaccination shots were given to them, these health workers were asked to wait for 30 minutes at the centres so that they are kept under observation, like in the actual vaccination plan,” PTI quoted an official as saying.
WWII veteran celebrates 100th birthday with vaccine shot
BBC reported that World War Two veteran Roy brought in his 100th birthday by receiving a shot of the COVID-19 vaccine in the UK. “You don’t get a 100th birthday every day,” he was quoted as saying by the report.
Four UK returnees test positive for new virus strain in Gujarat
Four people who recently returned to Gujarat from the United Kingdom (UK) have tested positive for the new strain of coronavirus, a top state health department official said on Saturday. Results of the 15 samples that had tested positive for coronavirus on arrival in Ahmedabad from the UK are currently pending with the National Institute of Virology (NIV) in Pune.
“All the passengers who had reached Ahmedabad from the UK were screened, and the samples of those who had tested positive for coronavirus were sent to the NIV. We have received intimation that the UK strain of coronavirus has been detected in four such cases,” Principal Secretary (Health), Jayanti Ravi told reporters.
London schools to remain closed as COVID-19 surges in Uk
The UK government has instructed all primary schools in London to remain closed and not return for the new term on Monday amid a surge in COVID-19 infections rates across England.
After an urgent review, the Department for Education (DfE) decided that the education contingency framework will be applicable across all of the UK capital instead of just a few boroughs.
It has led to growing calls from the Opposition and teachers’ unions for all schools in England to remain shut due to fears of adding to the pressure on the state-funded National Health Service (NHS) with already rising hospital admissions.
No new COVID-19 deaths reported in Puducherry
Puducherry reported a dip in new coronavirus cases with just 10 additions, taking the overall infection count to 38,174 on Saturday. The toll remained at 633 as there was no new death due to COVID-19 in the Union Territory.
There were 346 active cases after discharge of 30 patients in the last 24 hours ending at 10 am on Saturday which took the cumulative recoveries to 37,195, Director of Health and Family Welfare S Mohan Kumar said in a release.
India-UK flights to restart from 6 Jan, UK-India services from 8 Jan, says Centre
Union aviation minister Hardeep Singh Puri said on Saturday that flights from India to UK will resume from 6 January, while services from that country to India will resume from 8 January onwards. “Resumption of flights between India & UK: India to UK from 6 Jan 2021. UK to India from 8 Jan 2021. 30 flights will operate every week. 15 each by Indian & UK carriers,” Puri said on Twitter.
“This schedule is valid till 23 Jan 2021. Further frequency will be determined after review,” he added. Earlier, Puri had announced on Friday that only 30 flights per week will operate between India and the UK when services resume from 8 January and that this arrangement will continue till 23 January.
Assam reports 40 new COVID-19 cases, 4 fresh deaths
Assam’s COVID-19 tally rose to 2,16,251 with 40 more people testing positive for the infection, while four fresh fatalities pushed the toll to 1,049, a bulletin issued by the state government’s National Health Mission said on Saturday.
Four persons succumbed to the disease since Friday, taking the total toll to 1,049 with the current death rate at 0.48 percent while 1,347 COVID positive patients have died for other reasons.
Forty new cases have been reported out of 15,429 tests conducted at a positivity rate of 0.26 percent, it said.
Three cr frontline workers to get free vaccine in first phase: Harsh Vardhan
Free coronavirus vaccines will be given in the first phase to three crore people who have been on the frontline in the fight against the highly contagious disease, Health Minister Harsh Vardhan said Saturday.
The government will give priority to 1 crore healthcare workers and 2 crore frontline workers when India begins the rollout of the COVID-19 vaccine.
“In 1st phase of COVID-19 vaccination, free vaccine shall be provided across the nation to most prioritised beneficiaries that include 1 crore healthcare and 2 crore frontline workers. Details of how further 27 cr priority beneficiaries are to be vaccinated until July are being finalised,” Harsh Vardhan tweeted this afternoon.
Vaccine dry run carried out on 75 health workers in Madhya Pradesh
Nearly 75 health workers underwent dummy vaccination at Bhopal in Madhya Pradesh on Saturday as part of the first dry run of COVID-19 vaccine programme in the state, an official said.
The mock vaccination programme was conducted at three health centres in the state capital – Gandhi Nagar community
health centre (CHC), Govindpura CHC and LN Hospital, he said.
As part of the process, SMSs were sent to the health workers, in which they were asked to come to these health facilities, he added.
Vaccine dry run underway at Delhi’s Venkateshwar Hospital
Dry run for COVID19 vaccination administration underway at Venkateshwar Hospital in #Delhi
— ANI (@ANI) January 2, 2021
The mock drill is also underway at GTB Hospital and a healthcare centre in Daryaganj. pic.twitter.com/f4qGTJoCqy
Mandatory COVID-19 test for UK returnees on arrival between 8-30 Jan: Govt
All passengers coming from the UK between 8 and 30 January would be subjected to self-paid COVID-19 tests on arrival, the health ministry said in a standard operating procedure issued on Saturday.
Moreover, each passenger arriving from the UK would have to bring his or her COVID-19 negative report from a test done 72 hours prior to the journey, the SOP stated.
India had suspended all flights to and from the United Kingdom from 23 to 31 December to check the spread of the mutated, more contagious variant of coronavirus found there. Later, the suspension was extended till 7 January.
Harsh Vardhan says vaccine to be provided free of cost across India
Union Health Minister Harsh Vardhan on Saturday said that the COVID-19 vaccine will be provided free of cost across the country. The announcement comes amid a dry run for coronavirus vaccination is underway in all the States and Union Territories.
“Not just in Delhi, it will be free across the country,” he said.
Earlier today, Delhi Health Minister Satyender Jain said the vaccine for COVID-19 will be given free of the cost in the National Capital. “Yes, medicines and treatment are being provided for free in Delhi, anyway,” he said.
In 1st phase of #COVID19Vaccination free #vaccine shall be provided across the nation to most prioritised beneficiaries that incl 1 crore healthcare & 2 crore frontline workers
— Dr Harsh Vardhan (@drharshvardhan) January 2, 2021
Details of how further 27 cr priority beneficiaries are to be vaccinated until July are being finalised pic.twitter.com/K7NrzGrgk3
COVID-19 vaccine dry run to continue in Assam till actual dose arrives: Official
In order to prepare the medical staff and infrastructure, the dry run for the COVID-19 vaccine will continue regularly across Assam till actual vaccination takes place, a senior official said on Saturday.
Talking to PTI, National Health Mission (NHM) Mission Director Lakshmanan S said the Health Department does not want to leave any stone unturned to find out any lacuna in the system before administering the vaccine to the people of the state.
“Today, we are having the dry run at Gauhati Medical College and Hospital, Sonapur Civil Hospital and Khanapara State Dispensary. This is going to be a continuous process and we will be having dry runs till the actual vaccine comes to us,” he added.
Vaccine hesitancy was an issue even during polio immunisation: Harsh Vardhan
“Vaccine hesitancy was an issue even when we started polio immunisation drive but we must remember its success. I appeal to the people not to be misguided by rumours regarding safety and efficacy of COVID-19 vaccine. We will not compromise on any protocol before approving a vaccine,” said health minister Harsh Vardhan on Saturday.
Vaccine hesitancy was an issue even when we started polio immunisation drive but we must remember its success.
— Dr Harsh Vardhan (@drharshvardhan) January 2, 2021
I appeal to the people not to be misguided by rumours regarding safety & efficacy of #COVID19vaccine
We will not compromise on any protocol before approving a vaccine. pic.twitter.com/p6ZG3hzuMG
KK Shailaja oversees COVID-19 vaccine dry run in Trivandrum
Kerala health minister KK Shailaja reviewed the dry run for COVID-19 administration at Government Hospital, Peroorkada in Trivandrum on Saturday. “The mock drill is over here. Everything went smoothly. The exercise is being conducted in 4 districts,” said the state health minister.
Kerala: State Health Minister KK Shailaja reviews dry run for COVID-19 administration at Government Hospital, Peroorkada in Thiruvananthapuram. She says, "The mock drill is over here. Everything went smoothly. The exercise is being conducted in 4 districts". pic.twitter.com/K3xvibeJ7h
— ANI (@ANI) January 2, 2021
Safety of vaccine our prime concern, says Harsh Vardhan
Health Minister Harsh Vardhan, who visited the GTB Hospital in Delhi to review a dry run for the COVID-19 vaccination, said that the “safety of vaccine is the prime concern.”
“I want to assure all Indians that the vaccine is aimed at safeguarding your health,” he said, adding that “positive news” can be expected soon.
Harsh Vardhan appeals to avoid rumours on vaccine, says ’everything checked in detail’
There should be no misconceptions about the safety of the coronavirus vaccine that India plans to use as “everything has been checked in detail”, Union Health Minister Dr Harsh Vardhan said on Saturday.
The day-long drive tests COVID-19 Vaccine Intelligence Network (CoWIN), a digital platform to roll out and scale up the vaccination drive.
“There should be no rumours about the vaccine’s safety. Everything has been checked in detail. Initially when the polio vaccine was rolled out, even then rumours had floated. But once it went on the floor, all people were assured about the safety,” he said in New Delhi while reviewing the progress of the drive.
Dry run for COVID-19 vaccination begins in Delhi
A dry run for COVID-19 vaccination began in the National Capital on Saturday at three sites selected for the purpose, officials said.
The Centre had on Thursday stated that the activity was set to be conducted by all state and union territory administrations on 2 January to test the linkages between planning and implementation, and identify challenges.
Over 17.38 cr COVID-19 samples tested so far: ICMR
According to the Indian Council of Medical Research (ICMR), 17,39,41,658 COVID-19 samples have been tested till 1 January with 8,29,964 samples being tested on Friday alone.
India registers over 99 lakh COVID-19 recoveries
Up to 22,926 people have been cured of the novel coronavirus in the past 24 hours, taking the overall recoveries past 99 lakh. The number of active cases, or those receiving treatment, dropped to 2,50,183 – up to 4,071 fewer than Friday.
Active cases in India at 2.5 lakh
Reported active COVID-19 cases in India now stand at 2,50,183. As many as 99,06,387 COVID-19 patients have been cured and discharged so far, the Union health ministry has said in its latest update.
India’s COVID-19 toll nears 1.50 lakh
With the death of 224 more COVID-19 patients in the past 24 hours, the toll due to the novel coronavirus in India reached 1,49,218, the Union health ministry said on Saturday.
India’s daily COVID-19 cases drop below 20,000; total crosses 1.03 cr
The total confirmed coronavirus cases in India have risen to 1,03,05,788 on Saturday after 19,079 fresh infections were registered in a day, said the Union health ministry.
The figure includes cases involving foreign nationals, patients who have recovered and the toll.
COVID-19 dry run underway in Pune
Maharashtra: Dry run for #COVID19 vaccine administration underway at District Hospital, Pune
— ANI (@ANI) January 2, 2021
Vaccination drill is being conducted in all States/UTs today in 116 districts across 259 sites. pic.twitter.com/d8dW9jYOnm
Schools reopen in Kerala, Karnataka, Assam amid strict COVID-19 regulations
Corridors rang out with the chatter of students meeting up with their friends and teachers after long, anxious months on Friday as schools in Kerala, Karnataka and Assam reopened with strict COVID-19 regulations, including masks, thermal screening, hand hygiene and social distancing.
Though many students attended school with letters of consent from their parents, some chose to continue education online with their guardians anxious about the COVID-19 situation and the emergence of a new strain of the novel coronavirus.
India-UK air travel to resume from 8 Jan; 30 flights to operate per week
Only 30 flights per week will operate between India and the UK when services resume from 8 January, Civil Aviation Minister Hardeep Singh Puri announced on Friday and said this arrangement will continue till 23 January.
Indian and UK carriers will each be operating 15 flights per week during the aforementioned period to and from Delhi, Mumbai, Bengaluru and Hyderabad only, he said.
_**Read more here…**_India to hold dry run for vaccine across 116 districts today
India on Saturday will conduct a dry run ahead of the actual vaccination drive against the novel coronavirus in an end-to-end exercise where all steps will be tested across states and Union territories.
The activity will be conducted in all state capitals in at least three session sites and some states will also include districts that are remote.


The new human organ scientists discovered in 2020 can help fight cancer of head and neck: Research
Dutch scientists discovered a new organ in the human throat, the tubarial salivary glands, during prostate cancer imaging. This finding could revolutionize head and neck cancer care by refining radiation therapy, reducing side effects, and enhancing patient quality of life.
More Impact Shorts